American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
Becton Dickinson
BDX
|
+$281M |
| 2 |
iShares Russell Mid-Cap Value ETF
IWS
|
+$264M |
| 3 |
Evergy
EVRG
|
+$263M |
| 4 |
Waste Connections
WCN
|
+$235M |
| 5 |
Sun Communities
SUI
|
+$227M |
Top Sells
| 1 |
Quest Diagnostics
DGX
|
+$269M |
| 2 |
PNC Financial Services
PNC
|
+$266M |
| 3 |
SBA Communications
SBAC
|
+$242M |
| 4 |
Comerica
CMA
|
+$237M |
| 5 |
Hologic
HOLX
|
+$203M |
Sector Composition
| 1 | Technology | 21.04% |
| 2 | Healthcare | 15.96% |
| 3 | Financials | 13.8% |
| 4 | Consumer Discretionary | 12.94% |
| 5 | Industrials | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
601
Consolidated Edison
ED
$35.2B
| $13.5M | 0.01% |
187,023
+64,389
| +53% | +$4.63M |
|
602
Ultragenyx Pharmaceutical
RARE
$2.92B
| $13.4M | 0.01% |
171,687
+61,158
| +55% | +$4.78M |
|
603
Casella Waste Systems
CWST
$5.79B
| $13.4M | 0.01% |
257,597
-10,121
| -4% | -$528K |
|
604
Amicus Therapeutics
FOLD
$2.46B
| $13.3M | 0.01% |
884,786
+237,015
| +37% | +$3.57M |
|
|
BERY
605
DELISTED
Berry Global Group, Inc.
BERY
| $13.3M | 0.01% |
327,810
-12,612
| -4% | -$513K |
|
606
Zions Bancorporation
ZION
$8.62B
| $13.2M | 0.01% |
388,792
+130,362
| +50% | +$4.43M |
|
607
Bank of America Series L
BAC.PRL
$3.95B
| $13.2M | 0.01% |
9,838
-13,192
| -57% | -$17.7M |
|
608
Incyte
INCY
$16.2B
| $13.1M | 0.01% |
126,334
-100,401
| -44% | -$10.4M |
|
609
Halozyme
HALO
$8.99B
| $13.1M | 0.01% |
487,053
+54,556
| +13% | +$1.46M |
|
|
ARNA
610
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $13M | 0.01% |
207,258
-56,675
| -21% | -$3.57M |
|
611
Kinder Morgan
KMI
$61.3B
| $13M | 0.01% |
859,278
-967,194
| -53% | -$14.7M |
|
612
Freshpet
FRPT
$2.67B
| $13M | 0.01% |
155,639
-66,751
| -30% | -$5.58M |
|
613
Towne Bank
TOWN
$2.83B
| $13M | 0.01% |
689,540
+92,070
| +15% | +$1.73M |
|
614
Public Service Enterprise Group
PEG
$41.3B
| $13M | 0.01% |
264,243
+101,474
| +62% | +$4.99M |
|
615
RadNet
RDNT
$5.69B
| $12.9M | 0.01% |
+815,266
| New | +$12.9M |
|
616
Ceco Environmental
CECO
$1.7B
| $12.9M | 0.01% |
1,962,223
+192,375
| +11% | +$1.27M |
|
617
Trex
TREX
$6.48B
| $12.8M | 0.01% |
197,274
-130,312
| -40% | -$8.48M |
|
618
ASGN Inc
ASGN
$2.26B
| $12.7M | 0.01% |
191,020
-97,853
| -34% | -$6.52M |
|
619
Entravision Communication
EVC
$226M
| $12.6M | 0.01% |
8,779,073
+416,680
| +5% | +$596K |
|
|
JBGS
620
JBG SMITH
JBGS
$1.45B
| $12.5M | 0.01% |
421,346
+74,578
| +22% | +$2.21M |
|
621
Old National Bancorp
ONB
$8.88B
| $12.4M | 0.01% |
+904,391
| New | +$12.4M |
|
622
Kratos Defense & Security Solutions
KTOS
$11.7B
| $12.4M | 0.01% |
795,813
+420,917
| +112% | +$6.58M |
|
623
McDonald's
MCD
$218B
| $12.4M | 0.01% |
67,389
-28,989
| -30% | -$5.35M |
|
624
SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$41.9B
| $12.3M | 0.01% |
134,700
+30,800
| +30% | +$2.82M |
|
|
PRAH
625
DELISTED
PRA Health Sciences, Inc.
PRAH
| $12.3M | 0.01% |
126,362
-20,198
| -14% | -$1.97M |
|